The Pharmacy Times® Mental Health Resource Center is a comprehensive resource for clinical news and expert insights on conditions that affect mood, thinking, and behavior, including clinical depression, bipolar disorder, schizophrenia, anxiety, and post-traumatic stress disorder.
November 20th 2024
Lenora Newsome, PD, president of the National Association of Boards of Pharmacy, explores how pharmacists can support mental health.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Exploring Therapeutic Advances for Bipolar Disorder With Mixed Features and Anxious Distress: An Update for Ph...
2.0 Credits / Neurology, Psychiatry
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements
2.0 Credits / Psychiatry
View More
Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia
3.0 Credits / Psychiatry
View More
AbbVie Seeks FDA Approval for Cariprazine for Adjunctive Treatment of Major Depressive Disorder
February 23rd 2022In a phase 3 study, there were clinically and statistically significant changes observed from baseline to week 6 in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score for patients treated with cariprazine at 1.5 mg/day versus the placebo.
Read More
Reconciling Medications in Mental Health Assessments Protects Patients
Process helps prevent errors for individuals with chronic disorders who often have a higher risk of drug-drug interactions.
Read More
Expert: ‘Biology Plays a Really Important Role in Sexual Health’ for Women, Men
February 15th 2022Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses whether hypoactive sexual desire disorder is associated with psychological and/or emotional components.
Watch
Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic
February 10th 2022Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, explains how ketamine infusions work when administered in patients’ homes and what safety precautions would be taken by providers in this setting.
Watch
Inflammation in Childhood May Cause Depression, Psychosis in Adulthood
January 13th 2022Study data showed that increased levels of infection, inflammation, and metabolic alterations frequently observed in people with depression and psychosis may be a cause rather than a consequence of these disorders.
Read More